Form 4: Blackbaud Director Sells Shares Under 10b5-1 Plan

Blackbaud Director Rupal S Hollenbeck sold 1,600 shares of common stock for $56.49 per share on November 21, 2025, pursuant to a Rule 10b5-1 plan.

Summary

• Rupal S Hollenbeck, a Director at Blackbaud Inc. (BLKB), reported a transaction involving the company's common stock.
• On November 21, 2025, Hollenbeck disposed of 1,600 shares of common stock.
• The shares were sold at a price of $56.49 per share.
• Following this transaction, Rupal S Hollenbeck beneficially owns 6,366 shares of Blackbaud common stock.
• The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: The sentiment is neutral. While insider selling can sometimes be viewed negatively, the disclosure that the transaction was made under a Rule 10b5-1 plan suggests it was a pre-scheduled event, mitigating any immediate negative implications regarding management's confidence in the company's future.

Negatives

• Director Rupal S Hollenbeck sold 1,600 shares of common stock.

Future Outlook

NA

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans, are common in the technology and software industry as a means for executives and directors to manage their personal stock holdings in a pre-scheduled and compliant manner, reducing concerns about market timing.

Stakeholder Impact

• Shareholders may note the director's sale of shares, but the 10b5-1 plan context suggests it is part of a routine personal financial management strategy rather than a signal of declining confidence in the company.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-scheduled insider stock sale under a 10b5-1 plan. Such transactions typically do not provide new fundamental information about the company's performance or outlook that would warrant a change in investment recommendation. Investors should continue to evaluate Blackbaud based on its financial results, strategic initiatives, and market position.

Keywords

Blackbaud, BLKB, Insider Trading, Form 4, Stock Sale, Director Transaction, 10b5-1 Plan